SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-134516
Filing Date
2013-03-29
Accepted
2013-03-29 16:03:05
Documents
5
Period of Report
2013-05-23
Effectiveness Date
2013-03-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d512438ddef14a.htm DEF 14A 317011
2 GRAPHIC g512438g03c44.jpg GRAPHIC 107382
3 GRAPHIC g512438g33x98.jpg GRAPHIC 121212
4 GRAPHIC g512438g64i72.jpg GRAPHIC 16337
5 GRAPHIC g512438g95j55.jpg GRAPHIC 8747
  Complete submission text file 0001193125-13-134516.txt   668126
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35420 | Film No.: 13727799
SIC: 2834 Pharmaceutical Preparations